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I.  INTRODUCTION 
Over the past  20 yr, evidence has come from a 
variety  of  sources  to  suggest  that  the  primary 
event in the action of peptide hormones  1 and some 
neurotransmitters is binding to a  specific  site on 
the  plasma  membrane  of  the  cell  known  as  a 
receptor site. Most early studies attempted to de- 
fine these hormone receptors by studying the steps 
of hormone action in reverse order, i.e. by investi- 
gation of effects of various factors on hormonally 
induced biological responsiveness in intact animals 
or intact tissues. More recently, with development 
of methods for preparation of high specific  activ- 
ity, biologically active labeled hormones, and hor- 
monally responsive cells or cell membranes, direct 
study  of  hormone-receptor interactions has  be- 
come possible. Such studies have now been em- 
ployed for  a  wide variety of tissues and a  large 
number of peptide hormones and neurotransmit- 
ters  (for  a  list see  reference  73).  These  studies 
have resulted in a  significant increase in our un- 
derstanding of the  chemical nature of receptors 
and how they interact with their hormonal ligands. 
Many aspects of the hormone-receptor interaction 
have been discussed in previous reviews (11,  19, 
22, 73, 106, 123, 130). The purpose of this review 
is to bring together some concepts about the hor- 
The references and figures accompanying this article 
are not meant to be comprehensive and have been se- 
lected only to  illustrate certain points.  More detailed 
reference lists are found accompanying  those reviews. 
mone receptor as a component of the cell  mem- 
brane, the chemical nature of hormone receptors, 
and cellular regulation of hormone receptors  as 
they  relate  to  the  biology of the  cell.  Only the 
receptors for peptide hormones and for the cholin- 
ergic and the  fl-adrenergic neurotransmitters will 
be  considered.  Receptors  for  viruses,  immuno- 
globulins, and drugs demonstrate many features 
similar to those of the hormone receptors; how- 
ever, a review of these is outside the scope of this 
article. 
II.  METHODOLOGICAL 
CONSIDERATIONS 
The basic methodology employed for most direct 
studies of the hormone-receptor interaction is that 
used in other competitive protein binding assays 
(73).  An  isotopically  labeled  hormone  (hor- 
mone*) or hormone competitive antagonist is in- 
cubated  with  a  suitable  receptor  preparation. 
After some period of time the hormone*-receptor 
complex is separated from the free hormone* by 
centrifugation, filtration, or precipitation, and the 
receptor bound radioactivity is  determined. The 
specificity  and  saturability  of  this  reaction  are 
demonstrated by performing the incubation with 
various amounts of unlabeled hormone or related 
compounds. A  few  studies have  also  been con- 
ducted with photoaffinity probes (46) or with flu- 
orescent (13) or ferritin-labeled ligands (71, 110), 
but these latter techniques have not been widely 
applied. Methodologic problems related to choos- 
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preparation,  and  technique  of  separation  have 
been reviewed elsewhere in detail (73); however, 
several points regarding the hormone and receptor 
preparations deserve comment here. 
In  general,  direct studies  of the  peptide  hor- 
mone-receptor interaction have employed labeled 
agonists as the ligand in studying the binding reac- 
tion. In studies of the receptors for the neurotrans- 
mitters,  labeled  competitive  antagonists  have 
proved more useful. In the case of the /3-adrener- 
gic receptor, the  labeled antagonist provides the 
analogue  and  stereochemical specificity not  ob- 
served  in  studies  with  labeled  agonists  (2,  14, 
103).  With  the  cholinergic receptor,  antagonists 
such as snake venom  a-toxins have proved useful 
since they bind in an almost irreversible fashion to 
the  receptor  (19,  99,  106,  119),  although  they 
may occupy twice as many sites as acetylcholine 
itself  (119).  In  both  cases,  the  reasons  for  the 
discrepancies are not clear, but obviously reflect 
the  fact  that  the  agonist and  antagonist are  not 
binding to identical populations of sites. 
Of available radioisotopes, lz5I is the most use- 
ful  for  labeling peptide  hormones.  Tracers  pre- 
pared with one atom of 1~I per molecule have a 
sp. act. of about 2,200 Ci/mmol (73). In general, 
it appears that many of the monoiodohormones, 
including even molecules as small as/3-adrenergic 
antagonists, retain all or almost all of their biologi- 
cal activity (14,  73). Examples of both decreased 
and  increased  biological activity of labeled hor- 
mones may be found, however (73). 
Tissue preparations used as a  source of recep- 
tors have included intact cells, particulate fractions 
of cells, and "solubilized" fractions of cells. Each 
offers certain advantages and disadvantages. Iso- 
lated intact cell preparations have been obtained 
from  blood,  tissue  culture,  or  by  enzymatic  or 
mechanical  disruption  of  tissues.  These  offer  a 
major potential advantage in that they are usually 
metabolically active, making it possible to corre- 
late  hormone  binding and  biological effect  (15, 
41,  51,  82,  129,  153).  On  the  other  hand,  a 
number of undesirable side reactions such as hor- 
mone degradation may be higher with intact cells 
(45).  Furthermore, the types of enzymatic diges- 
tion  (often crude  collagenase, hyaluronidase, or 
trypsin) used to isolate cells can profoundly affect 
the concentration or affinity of a number of differ- 
ent hormone receptors (73, 82,153).  It is impor- 
tant to keep in mind the heterogeneity of cell types 
which compose most tissues  (which  may or may 
not be  morphologically distinguishable) and that 
the  receptor under study may be  restricted to a 
minority of the elements of the preparation (134, 
154).  Affinity-labeling and  autoradiography  are 
particularly useful in identifying the receptor-con- 
taining  cells  in  mixed  populations  (134,  154). 
Cells in  tissue  culture offer  the  greatest  ease  in 
isolation;  even  here,  however,  the  process  of 
adapting to culture, stage in cell cycle, and possi- 
ble transformation may affect the receptor popula- 
tion (see section VII). 
Particulate cell fractions often possess hormon- 
ally responsive  enzymes and  offer an  additional 
advantage with regard to stability during storage. 
In general, there is a distinct value in using more 
purified and well-characterized membrane prepa- 
rations,  since crude  particulate fractions contain 
internal organelles which may possess specific, as 
well  as  nonspecific,  hormone-binding  sites,  and 
hormone-degrading sites (vide  infra)  (105).  It is 
important  to  emphasize,  however,  that  every 
plasma membrane  isolation procedure is a  selec- 
tion  process in  which  only  10-50%  of the  total 
plasma  membrane  is  obtained.  Thus,  a  given 
membrane preparation may not be representative 
of the total plasma membrane. Furthermore, if the 
membrane  preparation obtained is from  a  tissue 
homogenate,  the  various cell types present  may 
contribute  preferentially to  the  final  membrane 
preparation.  For  this  reason,  every  membrane 
preparation must be assessed for yield, purity, and 
contamination  with  other  organelles,  especially 
when attempting quantitative comparisons in var- 
ious physiological and pathological states (105). 
Solubilized  fractions  of  cells  and  cell  mem- 
branes  have  proven  most  useful for  attempts  at 
purification and chemical characterization of the 
hormone  receptor.  Neutral  and  anionic  deter- 
gents, anionic bile salts, phospholipid emulsions, 
lithium diiodosalicylate, and even limited proteo- 
lytic digestion have  been  used  (21,  33,  52,  81, 
106,119,136,146).  Solubilized insulin receptors 
have  also  been  obtained  from  cultured  human 
lymphocytes without detergents (48). While many 
hormone receptors appear stable to solubilization, 
changes  in  both  affinity  (81,  136)  and  number 
(22) have been reported, presumably due to alter- 
ations in conformation or uncovering of "masked 
receptors" by disruption of membrane  phospho- 
lipids. In addition, the solubilized receptor suffers 
all of the problems of heterogeneity and contami- 
nation  that  the  original  insoluble  receptor  pos- 
sessed. Thus, it is necessary to establish the char- 
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ble preparation, so that nonspecific binding sites 
and degrading enzymes are distinguished from the 
true  receptors.  Finally, it  should  be  recognized 
that  it  is  erroneous  to  assume  that  the  soluble 
receptor  has  been  reduced  to  its  fundamental 
state; suspensions of small membrane vesicles or 
fragments or detergent micelles which contain sev- 
eral proteins may fulfill the criteria for solubiliza- 
tion and may be mistaken for an "isolated," solu- 
ble receptor in the hormone-binding studies. 
III.  IDENTIFICATION OF THE 
RECEPTOR 
There is general agreement that the term "recep- 
tor" refers to a  molecule (or molecular complex) 
which  is  capable  of  recognizing  and  selectively 
interacting with the hormone or neurotransmitter, 
and which, after binding it, is capable of generat- 
ing some  signal that initiates the chain of events 
leading to the biological response. Since receptors 
for peptide hormones and neurotransmitters have 
not yet been identified as purified chemical enti- 
ties, however,  some  confusion has resulted over 
what functional characteristics should be used to 
define them. This problem in identification has led 
to a series of semantic arguments and even several 
papers on the "molecular linguistics" of hormone 
action  (11,  61).  Some  investigators  have  sug- 
gested that the term receptor be reserved for situa- 
tions  in  which  both  components  of this  bifunc- 
tional element have been demonstrated, i.e. hor- 
mone binding and biological response, and that a 
hormone-binding site detected in the absence of a 
defined biological response be given an alternative 
name  such  as  "acceptor"  (11).  Using  this  ap- 
proach,  a  molecular complex  in  one  target  cell 
would  be  termed  a  receptor  if  a  biological re- 
sponse  could  be  demonstrated,  while  the  same 
complex in the membrane fraction of that cell or 
on  an  intact  cell  of  a  different  type  would  be 
termed an acceptor if no biological response could 
be demonstrated. This type of semantic distinction 
between receptor and acceptor is highly arbitrary 
and strongly biased by the limitations of the exper- 
iments. Insulin receptors, for example, have now 
been studied in some detail in intact cells, particu- 
late fractions,  and  solubilized preparations of at 
least 10 different tissues. Some of these tissues are 
classical target tissues for insulin action, while oth- 
ers are tissues not thought to be insulin responsive. 
In all cases, the major characteristics of the bind- 
ing reaction including kinetics, pH optimum, neg- 
ative  cooperativity, and  analogue  specificity are 
virtually identical  (50);  furthermore,  anti-insulin 
receptor antibodies block insulin binding in all of 
these (37). Thus, by all criteria, these binding sites 
appear to be the same or nearly the same mole- 
cules. 
To  avoid  such  semantic  confusion,  it  seems 
more  useful to define a  hormone  receptor as "a 
cellular component which has the ability to selec- 
tively recognize and bind the hormone and which 
has binding characteristics consistent with a poten- 
tial for signal generation." Most importantly, the 
binding should show specificity for hormonal ana- 
logues which parallels known biological effects of 
these hormones.  In addition, the kinetics of hor- 
mone-receptor interaction and the affinity of the 
receptor  for  the  hormone  should  be  consistent 
with the kinetics and dose response of biological 
action of the  hormone.  The  biological response, 
on the other hand, can be regarded as being gener- 
ated by a functionally separate unit, the effector. 
The receptor and effector functions may reside in 
the same single molecule, or more likely, reside in 
separate molecules which interact directly or indi- 
rectly in the fluid mosaic membrane (Fig. 1). Rel- 
atively large variations may be observed between 
hormone binding and biological response depend- 
ing  on  the  number  of steps  between  these  two 
processes and the manner in which the steps are 
coupled  (see sections VIII and IX).  In the most 
extreme situation, the cell could possess a normal 
receptor molecule in the total absence of the effec- 
tor molecules. In this case, no biological response 
would be observed despite the normal receptor. 
IV.  CHEMICAL  NATURE  OF HORMONE 
RECEPTORS 
No  hormone  receptor has been  isolated in suffi- 
cient quality and quantity for complete chemical 
characterization.  There  has  been  considerable 
progress in our understanding of the chemical na- 
ture of receptors, however, derived from a variety 
of  indirect  studies  such  as  effects  of enzymatic 
degradation  on  hormone  binding  and  from  at- 
tempts  to  isolate  and  purify  these  membrane- 
bound components (Table I). 
All of the  hormone  receptors that  have  been 
tested are susceptible, to some extent, to degrada- 
tion by one or more proteolytic enzymes, suggest- 
ing that in each receptor there is a protein compo- 
nent important for hormone recognition (73, 88, 
106,  127).  Important roles for membrane  phos- 
pholipids have  been  suggested for  the  receptors 
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FIGURE 1  Models of hormone  receptors and effectors.  Three simplified models of hormone  receptors 
and effectors are depicted. In the complex at the left, both the receptor and effector functions are present 
in a single transmembrane  molecule. In the complex at the center, the receptor and effector are separate 
molecules  but  directly  coupled.  In the  complex  at  the  right,  the  receptor and  effector  are separate 
molecules and coupled by a third (shaded) molecule. 
for adrenocorticotropin (ACTH), z glucagon, thy- 
rotropin  releasing  hormone  (TRH),  luteinizing 
hormone-human  chorionic  gonadotropin  (LH- 
hCG),  and  both  the  adrenergic  and  cholinergic 
neurotransmitters, all of which exhibit decreased 
hormone  binding  after  phospholipase  treatment 
(4, 73,106,  114). The receptors for insulin, thyro- 
tropin  (TSH), and the gonadotropins (LH-hCG) 
appear  to  have  important  carbohydrate  compo- 
nents.  The  TSH  receptor  loses  binding  activity 
when  exposed  to  neuraminidase  and  stains  for 
both protein and carbohydrate on polyacrylamide 
gel  electrophoresis  (146).  Insulin  receptors  and 
2 Abbreviations  used in  this paper:  ACTH, adrenocorti- 
cotropin; FSH, follicle stimulating hormone;  hCG, hu- 
man chorionic gonadotropin; LH, luteinizing hormone; 
MSA, multiplication-stimulating activity; NSILA-s, non- 
suppressible insulin-like activity soluble in acid-ethanol; 
TRH, thyrotropin releasing hormone; TSH, thyrotropin; 
and VIP, vasoactive intestinal polypeptide. 
gonadotropin receptors are unaffected by neura- 
minidase alone (23, 32), but the insulin receptor 
does lose binding activity after exposure to a com- 
bination  of  neuraminidase  and  /3-galactosidase 
(22). In addition, soluble preparations of all three 
types of receptors are bound by concanavalin A- 
Sepharose (24, 119,  146), although in the case of 
the insulin receptor this interaction appears to be 
through a site which is separate from the bioactive 
sites (26). Disulfide exchange has not been proven 
necessary for  any  hormone-receptor interaction; 
however,  some  receptors appear to  have  sulfhy- 
dryl groups in or near the active site as judged by 
susceptibility to p-chloromercuribenzoic acid or to 
N-ethyl-maleimide (34, 78). 
Estimated molecular weights of receptors which 
have  been  solubilized in  the  absence of denatu- 
rants have ranged from  140,000  to 550,000  (Ta- 
ble I).  Most solubilized peptide hormone  recep- 
tors have had estimated mol wt of about 200,000 
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Chemical Characteristics of Some Hormone Receptors 
Probable chemical  Sulfhydryl de-  Evidence  for  Estimated tool wl 
Receptor  nature  pendent  Estimated mol wl  subunits  of subunit  References 
~-adrencrgic  Lipoprotein  Yes  140,000-160,000  ?  -  87, footnote  3 
Cholinergic  Glycolipoprotein  Yes  230,000-550,000  Yes  70,000-90,000  (+  68,  78,  81,  98,  106, 
smaller)  122,  133 
Gonadotropin  Glycolipoprotein  Yes  194,000  Yes  90,000  32-34 
(LH-hCG) 
Glucagon  Lipoprotein  190,000  Yes  90,000  52, 80 
Insulin  Glycoprotein  No  300,000  Yes  75,000  21-24, 48, 51 
Prolactin  Protein  -  220,000  No  136 
TSH  Glycoprotein  -  280,000  Yes  166,000,  75,000,  146 
24,000 
(22, 32, 48, 52, 81, 136,  146). In some of these 
preparations,  it has been possible to demonstrate 
adenylate cyclase activity indicating the complex- 
ity of these solubilized preparations and suggesting 
the  close association of the receptor  and cyclase 
(32).  Density gradient  centrifugation  has  shown 
that  most solubilized  receptor complexes have  a 
relatively  low  sedimentation  coefficient,  a  high 
Stokes' radius,  and a high axial ratio.  Since inte- 
gral membrane proteins such as receptors gener- 
ally bind large amounts of Triton X-100 or other 
nonionic detergents when solubilized (0.2-1.4 mg 
per mg protein), the very similar features of most 
solubilized receptors may be the result of the high 
partial  specific  volume  of  the  complex  due  to 
bound detergent and to the asymmetry and abnor- 
mal hydration of these complexes (62, 98). 
Attempts to purify and chemically characterize 
hormone receptor have proceeded slowly. This is 
not  surprising  in  view  of  the  small  number  of 
molecules per cell  and the relative insolubility of 
these macromolecules. If one begins with a crude 
microsomal fraction which contains  0.2 pmol of 
receptor per milligram of protein and assumes that 
the receptor has only one binding site per 200,000 
daltons, complete purification (to asp act of 5,000 
pmol/mg protein) will require about a 25,000-fold 
enrichment. The density of acetylcholine receptors 
in  electric  tissue  from Torpedo  or electric eel is 
500-  to  5,000-fold  higher,  making  purification 
somewhat simpler (26). 
Purification of the acetylcholine receptor from 
electric tissue of fish has been pursued in several 
laboratories.  When extracted  with  Triton  X-100 
or  other  nonionic  detergents,  the  acetylcholine 
receptor  has  a  tool wt  of between  250,000  and 
550,000 daltons (17, 68, 98,106,  119). Purifica- 
3 Lefkowitz, R. J. Personal communication. 
tion has yielded milligram quantities  of receptor 
(19,  68,  78,  81,  99,  119,  133).  These  highly 
purified preparations have one neurotoxin binding 
site  per  70,000-90,000  daltons  (6-13  nmol  per 
mg protein)  (107,  157)  and  5-6%  carbohydrate 
(119),  suggesting  that  the  native  receptor  is  an 
oligomeric  glycoprotein.  On  electron  micro- 
graphs, the purified receptor appears as a ringlike 
particle  8-9  nm in  diam consisting of five to six 
subunits,  each  3-4  nm in  diam,  surrounding  an 
electron-dense  pit  (19).  Several different protein 
unit  patterns  have  been  observed  on  polyacryl- 
amide gel electrophoresis in SDS. The acetylcho- 
line receptor of the eel consists of two major types 
of subunits, one of 42,000 and another of 54,000 
tool wt  (68,  122) while  that from Torpedo  con- 
tains three of four major bands on SDS-polyacryl- 
amide  electrophoresis  varying  in  mol  wt  from 
26,000 to 64,000 (133,152). Since these compo- 
nents  no  longer  retain  the  acetylcholine-binding 
property,  it  is not clear which of these  compose 
the actual active binding site  of the receptor. 
Amino acid analysis of the acetylcholine recep- 
tors from four different species reveals a relatively 
high content of proline, aromatic amino acids, and 
polar amino acids and a low degree of hydropho- 
bicity (101).  UV circular dichroism spectroscopy 
of receptor from Torpedo  also has revealed a high 
content  of ordered  secondary structure  (34%  a 
helix and 27%  /3 structure). Although, the amino 
acid  composition  and  protein  subunit  structures 
are different in the acetylcholine receptors exam- 
ined, there has been a significant preservation of 
structure.  Furthermore,  immunization  of rabbits 
with  receptors  from  the  electric  eel  produces  a 
myasthenia gravis-like  illness  suggesting that the 
acetylcholine  receptors in these  two species pos- 
sess similar immunologic determinants  (112). 
The most extensively characterized and purified 
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for  the  gonadotropins  LH  and  hCG  which  has 
been prepared by Dufau and her co-workers (32, 
33).  When  gonadal  membranes were  solubilized 
with  Lubrol  PX  (ICI  America  Inc.,  Stamford, 
Conn.),  two  major  peaks  of  hormone  binding 
were  observed.  The  first peak  had  an  apparent 
mol wt of about 200,000 and was coincident with 
the  adenylate cyclase activity, while  the  second 
peak, with an approx, mol wt of 80,000, appeared 
to represent receptors which had been dissociated 
from a receptor-cyclase complex (32). Using affin- 
ity chromatography, Dufau et al. have purified the 
gonadotropin receptor to asp act of 2,500 pmol/ 
mg  protein  (33).  This  highly  purified  receptor 
retains  its affinity and  specificity for  gonadotro- 
pins, and is a single component on gel electropho- 
resis in  SDS  with  an approx,  mol wt of 90,000. 
This preparation appears to be about 25%  pure. 
Other  peptide  hormone  receptors  have  been 
purified in  only very small quantity or to  lower 
specific activity. These  include the  receptors for 
insulin  (21),  glucagon  (52),  and  prolactin  (13) 
(Table I). It is interesting to note that the solubi- 
lized prolactin  receptor has  a  higher affinity for 
hormone than the native receptor. 
Like  the  acetylcholine receptor,  the  receptors 
for the polypeptide hormones may be oligomeric 
complexes.  For  several  of  the  soluble  receptor 
preparations, it has been possible to demonstrate 
a  smaller  subunit  which  possesses  the  binding 
property of the  whole  receptor complex.  In  the 
case  of the  glucagon  receptor,  a  20,000-dalton 
molecule which binds glucagon has been detected 
after the  larger soluble receptor is exposed to a 
high concentration of glucagon (80). Similarly, an 
active 24,000-dalton fragment of the TSH recep- 
tor  has  been  produced  by  limited  proteolysis 
(146).  Preliminary studies in this laboratory also 
suggest that the soluble insulin receptor, which has 
a mol wt of about 300,000, is an oligomeric struc- 
ture probably comprised of four or more binding 
sites (51). 
V.  THE  BINDING  PROPERTIES  OF 
HORMONE  RECEPTORS 
The  binding of labeled hormones to their recep- 
tors  has  demonstrated  several  characteristics 
which have helped to form part of the functional 
definition  used  for  identifying receptors for  the 
peptide hormones and neurotramsmitters. 
1.  Hormone Binding to its Receptor is 
Rapid and Usually Reversible 
The  time course of hormone  binding to its re- 
ceptor is dependent  on  temperature  and  on  the 
concentrations of hormone and receptor. At 37~ 
steady states are observed within a  few minutes, 
while at lower temperatures a steady state may not 
be reached for hours (11, 12, 14, 38, 41, 47, 56, 
60, 74, 88, 96,119,127,140,151)  (Fig. 2). With 
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FIGUgE  2  Time-course  and  saturability  of  hormone 
binding to receptors. (Top) Time-course of insulin bind- 
ing to liver plasma membranes as a function of tempera- 
ture.  Mouse liver plasma membranes  (0.2  mg  protein/ 
ml)  were  incubated  with  lml-insulin  (20  pM)  at  the 
indicated temperatures.  The percent of lzsI-insulin spe- 
cifically bound is plotted as a function of time (adapted 
from reference  140). (Bottom) Insulin bound as a func- 
tion of insulin concentration.  Insulin binding to rat liver 
plasma  membranes  was  determined as  a  function  of 
insulin concentration  by adding increasing amounts  of 
unlabeled insulin to a tracer of l~l-insulin. The data are 
expressed  as  total,  specific,  and  nonspecific  insulin 
bound as a function of free insulin concentration. 
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association rate constants which have been deter- 
mined for the hormone receptor interactions have 
been  of  the  order  104-107  M -1  s -~  (Table  II). 
These rates are significantly lower than would be 
predicted for  a  simple diffusion limited process; 
for example, a hormone of 6,000 mol wt interact- 
ing with a  150,000-dalton receptor would be ex- 
pected to have a forward rate constant of 6  x  108 
M -1  s -1  (74).  This  suggests  that  most  random 
collisions do not result in a  binding reaction and 
that the reacting species almost certainly have to 
be  preferentially aligned or overcome an  activa- 
tion  energy.  Addition of an  excess of unlabeled 
hormone,  dilution  of  the  reaction  mixture  or 
changing pH results in a rapid dissociation of the 
bound tracer (Table II). The hormone dissociated 
from the receptor appears to be identical with the 
native hormone with respect to its physical proper- 
ties,  interaction  with  antibodies or  other  mem- 
brane  receptors,  and  biological activity (32,  42, 
88,  127). 
2.  There is a Finite Number of Receptor 
Sites on the Cell 
The quantitative aspects of the hormone-recep- 
tor interaction are complex. In all systems, binding 
has been considered to be the sum of at least two 
processes, one of which is saturable and has been 
termed "specific" binding, and the other of which 
is not saturable over the' range of concentrations 
studied and has been termed "nonspecific" (Fig. 
2). The latter is composed of low affinity binding 
to the membrane, as well as nonspecific trapping 
and  adsorption to the glass or plastic incubation 
tube. Whether binding of hormones to these low 
affinity nonspecific membrane sites plays any role 
in hormone  action is uncertain.  In studies of lac 
repressor binding to DNA, it has been suggested 
that binding to the nonspecific sites increases the 
rate of repressor binding to operator and is impor- 
tant for the regulation of the lac operon (95). In 
any case, in the physiological range, most binding 
occurs to the specific receptor sites, which by defi- 
nition are finite in number. The actual number of 
specific receptor sites for  the  peptide hormones 
and catecholamines has ranged from as low as 500 
to  as high  as  250,000  sites per cell  (Table  II). 
Acetylcholine receptors have  been  estimated  to 
exist in specialized electric tissue cells at concen- 
trations in excess of 1011 per cell (19). 
3.  Hormone Receptors Have a High 
Affinity for the Hormone 
A  variety of mathematical methods have been 
applied to the analysis of steady-state binding data 
in an attempt to derive affinity constants for the 
hormone receptor interaction (for a complete re- 
view of the  methods  and  their assumptions and 
limitations, see references  11,  26,  73,  123,  and 
124).  In  most  of  these  analyses,  the  hormone- 
receptor interaction is depicted as a simple reversi- 
ble bimolecular equilibrium, 
[II] + [R] ~- [H-'l]  (1) 
k  d 
and 
k~  [~--k] 
ka  [HI [R] 
-  K  (2) 
where  [H ] is the concentration of free hormone, 
[R ] is the concentration of unoccupied receptors, 
[H-R]  is  the  concentration  of hormone-receptor 
complexes, kQ and ka are the association and disso- 
ciation  rate  constants,  and  K  is  the  affinity or 
equilibrium constant for the reaction. This type of 
simple bimolecular reaction between  a  hormone 
and its receptor appears to be present for growth 
hormone  (90),  calcitonin  (96),  prolactin  (136), 
the  gonadotropins  LH-hCG  (32,  121),  and,  in 
some tissues, for the cholinergic (81,  119) or /3- 
adrenergic receptors (2,  14). In these, the appar- 
ent equilibrium constants for the binding reaction 
derived from steady-state data have ranged from 5 
x  105 M -1 for the interaction of acetylcholine with 
the cholinergic receptor to 5  ￿  101~ M -1 for the 
interaction of the/3-antagonist hydroxybenzylpin- 
dolol with  the  /3-adrenergic receptor (Table  II). 
Most  peptide  hormone  receptors  have  affinity 
constants of 10s-101~ M -~. In general, similar val- 
ues have been obtained from kinetic experiments. 
In many cases, the reaction appears to be more 
complex.  Several  hormones  have  equilibrium 
binding data which suggest that there are two or 
more classes or orders of binding sites which differ 
in  affinity for  the  hormone.  This  has  been  re- 
ported  for  receptors  for  ACTH  (88),  oxytocin 
(70), glucagon (137), TRH  (60), TSH  (102), in- 
sulin (74), acetylcholine (96,  107), and catechol- 
amines (89). In these, analysis of equilibrium and 
kinetic data has been more difficult. 
Recently, De Meyts and his co-workers (26-29) 
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.
 and Levitzki (92) have suggested that the complex 
binding isotherms in  many hormone-receptor in- 
teractions may be the result of site-site interactions 
or cooperativity among receptors. The reaction is 
considered positively cooperative if the binding of 
the first ligand increases the affinity of the recep- 
tor for the  second and  negatively cooperative if 
the binding of the first ligand decreases the affinity 
of the receptor for the second (26). 
Cooperativity in hormone binding to receptors 
appears  to  be  a  frequent  finding.  Homotropic 
(hormone-induced)  positive  cooperativity  has 
been suggested in some studies of the vasopressin- 
receptor interaction  (12,  70)  and  the  acetylcho- 
line-receptor interaction (35). Evidence for homo- 
tropic negative cooperativity, on the other hand, 
has  been  presented  in  studies  of  receptors  for 
insulin  (27,  29,  50),  TSH  (151), 4 TRH  (60), 
nerve growth factor (38), and in some studies of 
/3-adrenergic (94) and cholinergic (35) receptors. 
The decrease in receptor affinity observed at high 
receptor  occupancy  in  most  cases  of  negative 
cooperativity appears to be due to an increase in 
the  rate of dissociation of the  hormone-receptor 
complex.  These  kinetic  findings  are  important 
since, from steady-state analysis alone, it is impos- 
sible to distinguish negative cooperativity from site 
heterogeneity  (29).  Cooperative  effects  are  re- 
tained  in  solubilized insulin  (51)  and  TSH  (72) 
receptors, and  in  a  tryptic fragment of the TSH 
receptor (146). In the case of the insulin receptor, 
the negative cooperative interaction is associated 
with a decrease in size of the solubilized receptor 
(51),  perhaps  due  to  subunit  dissociation,  and 
results in about a  10-fold fall in receptor affinity 
(27, 28, 50). In addition, regions distinct from the 
bioactive site of the  insulin and  insulin  receptor 
molecules appear to be required for the coopera- 
tive effect (28). These findings suggest that some 
receptors can exist in at least two reversible con- 
formations:  a  "high  affinity" conformation from 
which the labeled hormone dissociates slowly and 
which  is present  at  low  occupancy,  and  a  "low 
affinity" conformation present at high occupancy 
from  which  labeled hormone  dissociates rapidly 
(27, 28). 
The  affinity of a  hormone  for a  receptor may 
also be altered by binding of a different ligand to 
the receptor (heterotropic cooperativity). This re- 
action has been most extensively studied with re- 
gard to the effect of the guanyl nucleotides on the 
4 Kohn, L. Personal communication. 
glucagon  (128,  142)  and  angiotensin  receptors 
(55).  In both of these, GTP stimulates the disso- 
ciation of these  hormones from  their respective 
receptors. Profound effects of guanyl nucleotides 
have been also observed in the action of several of 
the  peptide  hormones  and  catecholamines,  sug- 
gesting  that  the  guanyl  nucleotides  may  act  in 
concert with the hormone receptor as an aUosteric 
regulator of biological response  (10,  128).  Diva- 
lent cation concentration and pH also have pro- 
found effects on binding of some hormones, sug- 
gesting  that  these  too  may  act  as  heterotropic 
regulators of receptor affinity. 
Several  possible mechanisms  to  explain these 
various cooperative effects have  been  proposed. 
The most likely include conformational changes in 
the structure of oligomeric receptors, or polymeri- 
zation  (clustering) or depolymerization of recep- 
tors in the fluid membrane, or a  combination of 
these (26-29, 92). 
4.  The Binding Sites are Specific for the 
Hormone and Binding of the Hormone 
to the Sites can be Related to 
the Biological Effects of 
the Hormone 
This is the  major characteristic and essence of 
the functional definition of the hormone receptor. 
A  single hormone receptor binds only one type of 
hormone and binding of the hormone to this site 
can  be  correlated with  biological activity of the 
hormone. In practice, these properties are usually 
demonstrated by showing that there is competition 
for  binding  of labeled hormone  to  the  receptor 
only by unlabeled substances which are related to 
the  hormone  in  question,  and  more  specifically, 
that the relative potency of hormone analogues to 
compete for the binding sites is in direct propor- 
tion  to  their  bioactivities. Among  receptors  for 
peptide  hormones,  this property  has  been  most 
extensively  studied  for  the  insulin  receptor  by 
Freychet et al. (39, 44) and Gliemann and Gam- 
meltoft  (53).  These  investigators  have  studied 
over 40 insulin analogues, and, in every case, have 
shown  a close correlation between affinity of the 
analogue for the insulin receptor and its biological 
activity (Fig. 3).  Similar data exist for the  vaso- 
pressin receptor (12, 70), the fl-adrenergic recep- 
tor (2, 14,103), and the cholinergic receptor (19, 
106,  119) and to a lesser extent for other peptide 
hormone receptors. This high degree of biological 
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specificity  is in marked contrast to the specificity 
demonstrated by antibody-binding sites and  has 
allowed hormone-receptor studies to  be  used to 
map  the  structure-function relationships of  hor- 
mone molecules (65, 70,  116,  126) and also has 
been  applied  to  the  assay  of  plasma  hormones 
(77).  True  competitive  antagonists of  hormone 
action compete  for  the  binding site  but  do  not 
initiate the biological response (11,  103,  126). 
Hormones with similar biological activities may 
or may not share the same receptor. LH and hCG, 
for example, appear to act directly on the  same 
receptor  site  in the  gonad  (32,  121),  while  the 
closely related hormones secretin, glucagon, and 
vasoactive intestinal polypeptide appear  to  have 
separate receptor sites (31,  126,  127).  An inter- 
mediate case  is that of enteroglucagon which can 
bind to some, but not all, of the hepatic receptors 
for pancreatic glucagon (5). 
Hormones with some spectrum of overlapping 
biological activities present more complicated pic- 
tures.  Growth hormone, prolactin, and placental 
lactogen appear to act through at least two recep- 
tor  sites,  one  more  specific  for  the  growth  hor- 
mone aspect of these peptides (90) and the other 
more  specific  for the  lactogenic aspects of these 
peptides (136). Similarly, insulin has an overlap- 
ping  spectrum  of  activities  with  several  serum 
growth factors (nonsuppressible insulin-like activ- 
ity soluble in acid-ethanol [NSILA-s], multiplica- 
tion-stimulating activity [MSA], and the somato- 
medins) (149).  Again, these  activities appear to 
be  mediated  by one  receptor  which  has  a  high 
affinity for  insulin and  a  lower  affinity for  the 
growth factors which mediates the acute metabolic 
effects of these peptides and one or more recep- 
tors which  have  a  higher affinity for the growth 
factors than for insulin which are thought to me- 
diate  the  growth  factors  of  these  peptides  (97, 
149). 
VI.  SUBCELLULAR LOCALIZATION 
OF  RECEPTORS 
Receptors for peptide hormones and neurotrans- 
mitters are  in their highest concentration on the 
plasma membrane of the cell. This finding is sup- 
ported by direct studies of labeled hormone bind- 
ing to intact cells (15, 39, 41,55, 82,153) and by 
the finding that the receptor concentration is en- 
riched  30-100-fold  during  purification  of  the 
plasma membrane (44, 73,  105). Several investi- 
gators, however, have found binding sites for pep- 
tide hormones and catecholamines on intracellular 
organelles (10, 72, 75). Fractions of both smooth 
270  THE  JOURNAL  OF  CELL  BIOLOGY"  VOLUME  70,  1976 and rough endoplasmic reticulum, Golgi appara- 
tus,  and  even  nuclei  5 all have  hormone  binding 
sites (Fig. 4, and references 9, 66). Some of these 
sites have an affinity and specificity for hormone 
analogues similar to that of the plasma membrane 
receptor, while others do not (bottom of Fig. 4). 
Whether these are true receptors in the process of 
synthesis or  degradation  or some  other  type of 
hormone-binding sites remains to be determined. 
Awareness of these nonplasma membrane sites is 
important  when  studying crude  particulate frac- 
tions of cells, since in these fractions intracellular 
organelles may contribute a larger fraction of pro- 
tein than the plasma membrane  (105). 
On the plasma membrane itself, receptors may 
not be homogeneously distributed. The  most ex- 
treme example of this is the cholinergic receptors 
which  have  been  estimated  by  immunofluores- 
cence  and  autoradiography studies to be heavily 
clustered  in  subsynaptic  areas  (10,000-100,000 
per/zm  2) while having only 0.01  this density out- 
side of the  synapses (13,  19).  Peptide hormones 
may  also  show  some  degree  of polarization  or 
clustering of receptors. Using ferritin-labeled insu- 
lin, Orci et  al.  (i10)  and Jarett and  Smith  (71) 
have studied the  distribution of insulin receptors 
on liver and fat cell membranes. In both cases, the 
insulin-binding sites were observed at a density of 
about 90 receptors per /xm z. In some areas, the 
receptors were diffusely distributed while in other 
areas clusters containing 3-12 ferritin insulin mol- 
ecules were seen (Fig. 5). The receptors appeared 
to be associated with the glycocalyx of the adipo- 
cytes  (71),  and  in  freeze-etched preparations of 
liver membranes the binding sites corresponded to 
intramembrane  particles  which  could  be  seen 
embedded in the phospholipid bilayer (110).  No 
receptors were found on the inside of the adipo- 
cytes  or  liver  membranes  by  this  technique  or 
could be found by direct study of inverted mem- 
brane vesicles prepared from adipocytes (7), sug- 
gesting that  the  receptors face only the  external 
surface of the plasma membrane. 
In almost all systems, the major site of hormone 
degradation appears to be separate from the hor- 
mone  receptor site.  This  has  been  most  clearly 
demonstrated in the case of acetylcholine-esterase 
and the acetylcholine receptor which can be physi- 
cally separated by gel filtration or density gradient 
fraction in the presence of detergents (19,  106). 
With peptide hormones and catecholamines, the 
5 Goldfine, I. D. Personal communication. 
separation of these  two active sites has been in- 
ferred from differences in specificity, affinity, opti- 
mal  conditions  for  binding  vs.  degradation  and 
effects  of enzyme  treatment,  temperature,  and 
specific inhibitors (30, 42,  106). While hormone- 
degrading enzymes can be demonstrated in puri- 
fied plasma membrane  fractions of the  cell, the 
total  activity  is  usually greater  in  less  purified 
fractions, suggesting that some hormone degrada- 
tion may take place intracellularly (41). 
VII.  REGULATION  OF HORMONE 
RECEPTOR  CONCENTRATION 
Like other components of the  cell, the constitu- 
ents  of the  plasma  membrane  are  in  a  state  of 
continual  turnover.  Membrane  proteins have  an 
average half-life of 30-60 h, with a range of 2 h to 
16 days for various specific membrane-associated 
enzymes  (132).  The  concentration  of  hormone 
receptors,  like  that  of other  membrane  compo- 
nents, is not fixed, but is a reflection of a state of 
continual synthesis and degradation. Any change 
in the rate of synthesis or degradation will result in 
a  change in the concentration of hormone recep- 
tor. Over the past 3-4 yr, a variety of studies have 
suggested that  changes in  plasma membrane  re- 
ceptor concentrations provide a potential mecha- 
nism for regulation of target cell sensitivity to the 
hormone. 
At present,  very little is known  about normal 
rates of receptor turnover. Studying rat diaphragm 
in tissue culture by a prelabeling technique, Berg 
and Hall (8) found that only 20% of acetylcholine 
receptors were lost per 24 h from innervated mus- 
cle and that  this loss increased to 80%  per 24 h 
when  the  muscle  was  denervated.  Inhibitors  of 
energy and protein synthesis decreased the rate of 
loss. In cultured human lymphocytes, turnover of 
growth  hormone  and  insulin  receptors has  been 
estimated  by  blocking  synthesis with  cyclohexi- 
mide;  growth  hormone  receptors  have  a  tzjz  of 
about 10 h (91) while insulin receptors have a tl/2 
of 30-40 h. 6 
A  variety of factors regulate the concentration 
of receptors.  One  major  factor  is  the  hormone 
itself. Data from a  variety of animal and human 
disease models have demonstrated an inverse rela- 
tionship  between  the  serum  concentration  of  a 
hormone  and the concentration of its membrane 
receptors. In the very hyperinsulinemic and insu- 
lin-resistant obese-hyperglycemic mouse, there is 
6 Kosmakos, F., and Roth, J. Manuscript in preparation. 
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Z72 FIOORE  5  Ferritin-insulin binding to liver plasma membranes as viewed in the electron microscope. 
Purified liver plasma membranes have been split by freeze-fracturing  to expose the inner matrix containing 
intramembranous particles (FF, fracture face), and deep-etched to expose the outer surface (S)  of the 
membrane. The outer surface of the membrane shows clusters of ferritin-insulin  molecules (enclosed by the 
solid circles) which appear  similar to  the  clusters of intramembranous particles on the  fracture face 
(enclosed by the broken circles). The arrows mark the ridge which separates the outer surface from the 
fracture face. ￿  90,000. Courtesy of L. Orci et al. (110). 
a  50-70%  decrease in the  number of insulin re- 
ceptors on hepatocytes (75, 76,  140), adipocytes 
(43), thymocytes (139), and cardiac muscle (40) 
(Fig. 6). The receptors which remain appear to be 
normal  in  their  affinity for  insulin, kinetics of 
association and dissociation, temperature depend- 
ence of binding, biological specificity, and nega- 
tive  cooperative  interactions  (140).  Similar de- 
creases  have  been observed in other genetically 
obese and insulin-resistant  mice (6,  141), in nor- 
mal  mice  made  obese  and  insulin resistant  by 
administration of gold thioglucose  (141),  and in 
rats  made  insulin resistant by  administration of 
steroids or implantation of pituitary tumors which 
secrete ACTH and GH1  (59, 108). Furthermore, 
insulin receptors on circulating mononuclear leu- 
kocytes  from  a  hyperinsulinemic thin  or  obese 
man are decreased and the magnitude of the de- 
crease correlates well with the degree of hyperin- 
sulinemia (1,  109).  Conversely, insulin-deficient 
states in animals are associated with an increase in 
the concentration of insulin receptors on the cell 
membrane (57, 63, 141). In each case, when the 
cause of the  altered insulin concentration is cor- 
rected, e.g., dieting the obese animals, the insulin 
receptor concentration returns toward normal. 
This alteration in insulin receptors is a specific 
membrane alteration. In the obese hyperglycemic 
mouse which  has  been most  extensively studied 
(75,  76,  140,  141),  fully purified plasma mem- 
brane fractions of liver of the ob/ob mouse dem- 
onstrate a  70%  decrease in insulin receptors but 
remain identical to  those  of the  thin littermates 
with respect to morphologic appearance, activities 
of  5'-nucleotidase,  and  adenylate  cyclase,  and 
protein  subunit  composition.  In  addition,  the 
membrane  receptors  for  glucagon,  growth  hor- 
mone, and isoproterenol are not altered in these 
animals (Fig. 6). Chang et al. (16) have suggested 
that the decrease in insulin receptors is a part of a 
more  generalized alteration in membrane glyco- 
proteins since lectin binding to crude membrane 
fractions  and  enzymatically treated  cells  is  also 
decreased. This interpretation does not seem war- 
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ranted since the cell membrane glycoproteins may 
certainly have been altered by the enzyme treat- 
ment employed. Furthermore, the value of lectin 
binding as a quantitative marker for plasma mem- 
brane glycoproteins in crude particulate fractions, 
especially in animals with disordered carbohydrate 
metabolism, is unproven. It is difficult to envision 
a  severe  generalized defect  in membrane glyco- 
proteins which  would have  little effect  on other 
aspects of the membrane structure and function. 
In vivo a variety of other examples of inverse 
regulation of a receptor by its hormone have been 
observed. Parathyroidectomy, which decreases se- 
rum caleitonin concentrations, is associated with 
increased calcitonin binding to membranes of rat 
kidney  (143).  This  effect  can  be  prevented  by 
administration of exogenous calcitonin. Similarly, 
denervation of muscle increases acetylcholine re- 
ceptors and acetylcholine hypersensitivity (36). A 
decrease  in /3-adrenergic receptor sites occurs on 
the erythrocytes of frogs treated with/3-adrenergic 
agonists (104) and on pineal cells of rats treated in 
vivo with L-isoproterenol or stimulated physiologi- 
cally by prolonged exposure  to  dark  (79).  Both 
the frog erythrocytes and pineal cells  show a de- 
crease  in  isoproterenol-stimulated adenylate cy- 
clase  which  parallels  the  decrease  in  receptors, 
while basal and fluoride-stimulated adenylate cy- 
clase remain unchanged. Administration  of potent 
/3-adrenergic antagonists does not alter the level of 
the  catecholamine receptor, but may prevent its 
modulation by agonists (87).  /3-adrenergic recep- 
tors  on  rat  pineal cells  also  exhibit  a  circadian 
periodicity which is inversely related to the cycle 
of  neurotransmitter release,  suggesting that  this 
self regulation of receptors occurs physiologically 
(79). 
Direct effects of hormones on their own recep- 
tor  sites  have  also  been  demonstrated  in  vitro. 
Gavin et  al.  (49)  have  found a  time-dependent 
loss of insulin receptors when the human lympho- 
cytes were  cultured in media containing insulin. 
With each insulin concentration, a particular rate 
of loss  and steady-state level was achieved (Fig. 
7). Analogues of insulin which vary in biopotency 
and affinity for the insulin receptor exert this regu- 
latory effect in direct proportion to their bioactivi- 
ties; the effect is also observed with insulin ana- 
logues which  cannot induce the  site-site interac- 
tions among insulin receptors, suggesting that the 
mechanism  of  regulation  and  cooperativity  are 
independent.  6 When the cells are returned to me- 
dium free of insulin, there is a return of receptors 
to  normal levels within  16  h.  Both  the  "down 
regulation"  of  receptors  and  the  return  are 
blocked by cycloheximide. 
In the  same human lymphocyte line, negative 
feedback regulation of growth hormone receptors 
by growth  hormone has also been demonstrated 
(91). This effect can be seen with concentrations 
of growth hormone as low as 10 -l~ M. This effect 
is reversed upon removal of the hormone, and the 
recovery  can  be  blocked  by  cycloheximide. 
Growth hormone has no effect on the concentra- 
tion of insulin receptors, and vice versa. 
In vitro  negative feedback  regulation by hor- 
mones of their own receptors has also been ob- 
served in studies of TRH receptors in rat pituitary 
cells (64) and/3-adrenergic receptors in frog eryth- 
rocytes (100). In both, the ability of analogues to 
regulate  receptor  concentration corresponds  to 
their biological activity. Furthermore, the  effect 
on /3-adrenergic receptors is produced only by /3- 
adrenergic agonists, is accompanied by a decrease 
in catecholamine-sensitive adenylate cyclase, and 
may be blocked by competitive antagonists (87). 
Self regulation of membrane receptors is a com- 
mon  phenomenon  (118),  although  the  exact 
mechanism by which it occurs is uncertain. In most 
cases  it  appears  that  binding of the  ligand pro- 
motes degradation of the receptor by either mem- 
brane-associated proteases, endocytosis, or shed- 
ding of the  hormone-receptor complex into the 
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medium. The  hormone-induced losses of insulin 
and TRH receptors appear to require protein syn- 
thesis  (64).  8 Huang  and  Cuatrecasas  have  sug- 
gested  that observed regulation of insulin recep- 
tors by insulin is due to intrinsic proteolytic activ- 
ity  of  the  insulin itself  (67).  This  seems  highly 
unlikely in view of the specificity of the regulatory 
phenomenon, the  close  correlation of regulatory 
potency of  a  hormone  and  its  biological effect, 
blockade of the effect in some cases by cyclohexi- 
mide, and the widespread occurrence of this regu- 
latory mechanism for other types of receptors. 
In addition to the negative self-regulation a hor- 
mone  may  exert  on  its receptors,  Posner et  al. 
have presented indirect evidence that the prolactin 
receptor  is  under  positive  feedback  regulatory 
control  by  prolactin  (115).  Heterologous  hor- 
mones may also influence receptor concentration. 
Follicle stimulating hormone  (FSH)  administra- 
tion to animals appears to result in an increase in 
the  number of  LH  receptors  (or  cells with  LH 
receptors) in the ovary (154), while adrenal ster- 
oids  modulate  both  the  number of  vasopressin 
receptor sites and coupling of the receptor to the 
hormonal-sensitive adenylate cyclase  (120). 
Other  factors  which  influence the  cell  mem- 
brane may also influence the concentration of hor- 
mone  and  neurotransmitter receptors  on  cells. 
Thomopouios et al. have found a marked increase 
in concentration of insulin receptors on fibroblasts 
as the  cells  enter a  confluent, stationary growth 
phase  (147).  Several  groups  have  reported  the 
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ture of myogenic cell lines (111,145). In the latter 
case, there is also increased clustering during the 
differentiation of the cell. The most dramatic cell 
cycle effect is that described by Varga et al. who 
noted MSH receptors and stimulation of tyrosin- 
ase activity by MSH on a melanoma cell line only 
during the G2 phase of the cell cycle (150). In each 
of these cases, the major change appears to be in 
receptor number, not affinity. 
At present, the effect of malignant transforma- 
tion  on  the  concentration of hormone  receptors 
concentrations has been investigated only for insu- 
lin receptors. Thomopoulos et al. have found that 
the concentration of insulin receptors on BALB/ 
3T3  fibroblasts transformed  by  a  variety of vi- 
ruses,  X  ray,  methylcholanthrene  or  sponta- 
neously is low and  in  the  same  range  as that of 
rapidly growing normal ceils (147).  Insulin bind- 
ing  increases  as  the  transformed  cells  reached 
higher densities in  culture,  but  not to  the  levels 
seen in normal cells. In contrast,  Krug et al. re- 
ported an increase in the concentration of insulin 
receptor on  lymphocytes after activation by con- 
canavalin A  (85). However, the dose of concana- 
valin A  used was toxic to a large percentage of the 
cells and  much  of the  insulin  binding  observed 
showed  poor displacement by unlabeled insulin, 
suggesting  a  low-affinity type  of binding.  Rabi- 
nowitz et al. found no increase in insulin receptors 
on lymphocytes transformed with a low, nontoxic 
dose of concanavalin A  (117). 
Three points regarding all of the studies of re- 
ceptor  regulation  deserve  comment.  First,  the 
proper denominator for receptor concentration is 
uncertain. It is not clear whether cellular sensitiv- 
ity is most clearly related to the number of recep- 
tors per cell, per square micrometer, per receptor 
cluster, per milligram membrane  protein, or per 
unit adenylate cyclase and 5'-nucleotidase activity. 
This becomes an important issue when  a cell un- 
dergoes significant hypertrophy, as the adipocyte 
does in obese animals. In such cases, therefore, it 
is important to  measure  as many  aspects of cell 
membrane function as possible. At present, hor- 
monal sensitivity seems to correlate best with the 
number of receptors per unit surface area. A  sec- 
ond  major problem is technical and  arises from 
cellular heterogeneity and  possible difference in 
selection of cell or membrane  populations when 
studying tissues or cells in different states. These 
considerations stress the need for a careful charac- 
terization of the tissue preparation being studied 
(see reference  105  for a  detailed discussion). Fi- 
nally, it is worth noting that alterations in receptor 
affinity may also occur and play a role in altering 
cellular sensitivity to hormone  (77).  At present, 
no studies have clearly demonstrated synthesis of 
a mutant or abnormal receptor protein. 
VIII.  COUPLING  OF HORMONE 
RECEPTORS  TO  HORMONE 
EFFECTORS 
There have been a number of attempts to quantia- 
tively correlate the  binding of a  hormone  to  its 
receptor and the biological effects of the hormone. 
In most  of these,  the  hormone  receptor-effector 
complex  has  been  treated  as  a  single  molecule 
(Fig.  1,  left),  and  the  modeling  has  followed a 
simple  receptor  occupancy  theory  (18).  In  this 
case, the response of a target tissue to a hormone 
is considered directly proportional to the number 
of receptor sites filled, i.e., Effect =  a  [HR  ]. This 
implies that a  maximal response is obtained only 
when all receptors are occupied and that the bind- 
ing and biological response curves are superimpos- 
able over their entire range. Such a close quantia- 
tive  correlation is rarely observed.  Three  devia- 
tions  from  the  occupancy model  have  been  fre- 
quently noted. 
First, in a variety of systems a maximum biologi- 
cal response  is achieved with only a  minority of 
receptors occupied. For example, maximal stimu- 
lation of glucose oxidation by isolated adipocytes 
occurs when  only 2-3%  of insulin receptors are 
occupied  (bottom of Fig.  8)  (82,  97);  similarly, 
maximal stimulation of steroidogenesis by Leydig 
cells occurs when only 1%  of LH-hCG receptors 
are occupied (15). The additional 97-99%  of re- 
ceptors have  been  termed  "spare"  or  "reserve" 
receptors.  These  should  not  be  considered with 
inactive receptors.  Other  biological responses in 
these or other cells may require greater levels of 
receptor occupancy (83) (top of Fig. 8). Further- 
more, at present, there are no data to suggest that 
the 1-3% of receptors necessary for these biologi- 
cal responses differ from the remainder. 
A  second type of deviation from the occupancy 
model has been  observed in  which  there  are  no 
spare receptors, but the biological effect is not a 
simple linear function of receptor occupancy. For 
example,  adenylate  cyclase activation  by  lysine- 
vasopressin  is  80%  of  maximum  at  only  10% 
receptor occupancy, although complete saturation 
of the  receptor sites is required to obtain  maxi- 
mum  activation (12, 70). Furthermore, the bind- 
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ing of lysine-vasopressin is positively cooperative 
(Hill coefficient =  1.42), while the activation of 
the adenylate cyclase by lysine-vasopressin is neg- 
atively cooperative (Hill coefficient =  0.35). The 
degree  of nonlinearity is variable  depending on 
the vasopressin or oxytocin analogue studied (70). 
A  similar  type  of  nonlinear  coupling  has  been 
found  for  glucagon  binding  and  cyclic  AMP 
(cAMP) generation in isolated hepatocytes (129). 
Despite  the  spare  receptors and  nonlinear  cou- 
pling,  Gliemann et  al.  (54)  and  Bockaert et  al. 
(12)  have  found  close  correlations between  the 
time course of receptor occupancy and the onset 
of biological effects with insulin and vasopressin. 
Finally, deviations from the simple occupancy 
model can  occur due  to  differences in  "intrinsic 
activity" of the hormone analogues; different ana- 
logues  may  have  varying  capacity  to  initiate  a 
biological response after occupying the receptor. 
In  the  most  extreme case,  a  hormone  analogue 
may produce no biological response upon occupy- 
ing the receptor; this is the case of the true com- 
petitive antagonist.  Compounds  with  a  low effi- 
cacy  in  inducing  a  biological  response  possess 
properties intermediate between agonists and an- 
tagonists and have been termed "partial agonists." 
While examples of antagonists and partial agonists 
are plentiful in the studies of neurotransmitters (2, 
14,103,  119), in most cases, decreased biological 
potency of a peptide hormone analogue is due to a 
decreased affinity for the receptor rather than an 
alteration in  "intrinsic activity" (see Fig. 3) (39, 
44, 53, 70). 
The  failure to  observe  a  close correlation be- 
tween hormone action and direct measures of the 
hormone binding to its receptor is not surprising in 
view  of  the  constraints  imposed  by  the  simple 
model of a  single molecule which possesses both 
receptor  and  effector  functions  (Fig.  1,  left). 
Clearly, the model must be more complex to ac- 
count for already known cooperative interactions 
among  receptors  (26-29,  35,  70,  92,  94)  and 
regulatory effects of guanyl nucleotides, Mg, and 
other heterotropic effects on hormone binding or 
adenylate cyclase (10, 55,128,142).  In addition, 
a model which employs separate mobile molecules 
for the receptor and effector functions which pref- 
erentially interact when  the receptor is occupied 
by hormone  would  help to  explain spare  recep- 
tors, nonlinear coupling, and possible differences 
in intrinsic activity. Such a  model is discussed in 
more detail below. 
IX.  RELATIONSHIP  OF  HORMONE 
RECEPTORS  TO  A  FLUID 
MOSAIC  MEMBRANE 
In 1972 Singer and Nicolson (138) introduced the 
fluid mosaic membrane model. In this model, the 
membrane is pictured as a two-dimensional solu- 
tion  of globular integral proteins dispersed in  a 
relatively fluid lipid bilayer. Some  of these  pro- 
teins extend completely through the bilayer, while 
others are partially embedded in or on the surface 
of the membrane. Further, some membrane com- 
ponents appear relatively immobile, while others 
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mone receptors appear 1o be integral membrane 
proteins, i.e. they require strong detergents capa- 
ble of breaking hydrophobic bonds for dissocia- 
tion from the membrane and are usually insoluble 
in neutral aqueous buffers. At present, it is not 
known whether  these  receptors  span  the  entire 
membrane or are partially embedded in the mem- 
brane, whether they are relatively mobile or im- 
mobile, or whether they are monomeric or oligo- 
meric. 
The concept that  membrane fluidity may play 
an important role in hormonal activation of cellu- 
lar  processes  was  also  originally  proposed  by 
Singer  and  Nicolson  (138)  and  has  since  been 
amplified by Perkins (113), Cuatrecasas (22), de 
H~ien (25), and others (26-29, 92). Coupled with 
possible ligandoinduced changes in receptor con- 
formation,  this  may  offer  a  more  complex  but 
complete picture of hormone membrane interac- 
tion. 
In these models, the hormone receptor (R) and 
effector  (E)  are  depicted  as  separate  integral 
membrane components which are capable of dif- 
fusing laterally in the membrane plane. Hormone 
activation of a cell is then the result of at least two 
sequential steps: 
H  +R~-HR  (1) 
which occurs on the surface of the membrane and 
H--R + e  ~- HR-'Ez'E-  (2) 
which occurs within the membrane. Such a model 
is depicted in a highly schematic fashion in Fig. 9. 
In some cases, a third intermediate component has 
been postulated which couples the HR complex to 
the  effector  (Fig.  1,  right).  This general model 
provides a  means for explaining spare  receptors 
and nonlinear coupling of receptors and effectors 
and would present a possible mechanism by which 
multiple hormones could affect  a  single effector 
system and a  mechanism by which a  single hor- 
mone could influence multiple effector systems. 
In the simplest case, the membrane contains a 
1:1 stoichiometric relationship between receptors 
and effectors  (Receptor 2 in Fig. 9) and the HR 
complex is highly mobile and has a high affinity for 
the effector. In this case, every receptor occupied 
would  be  rapidly  coupled  to  effector,  and  the 
biological response would be a direct function of 
the  percentage  of  the  total  receptor  population 
occupied  by  hormone.  Alternatively,  receptors 
and effectors may not be present in stoichiometric 
amounts (25, 113) (Receptor 1 in Fig. 9.). Spare 
receptors would simply be the result of an excess 
of receptors with respect to effectors of the given 
biological response. If a  single class  of receptors 
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MOSAIC MEMBRANE 
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FIGURE 9  A highly schematic model of hormone receptors in a fluid mosaic membrane. Receptors for 
two hormones are depicted. Receptor 1 exists in an oligomeric  state and depolymerizes  upon binding of the 
hormone.  The  free receptor  subunits then  migrate and  interact with effectors. Since there  are  four 
receptors per effector, there would appear to be spare receptors. Receptor 2 exists as a monomer and in a 
one-to-one ratio with the effector; there are no spare receptors in this case. This is a highly schematic 
representation and numerous other possibilities  exist, including polymerization or clustering of receptors 
upon hormone binding. (Modified after references 22, 25, 113, 138.) 
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number of spare receptors may differ for the two 
systems. For example, only about 3%  of insulin 
receptors need to be occupied to produce maximal 
glucose  oxidation  in  adipocytes (43,  82),  while 
nearly 100%  need be occupied to produce maxi- 
mal amino acid transport in thymocytes (58) (Fig. 
8). In the first case there appear to be 30 receptors 
for every effector, while in  the  second the  ratio 
appears to be 1:1 or more. 
Different types of receptors and effectors may 
also be capable of interacting. A  single adenylate 
cyclase, for example, might be stimulated by more 
than one hormone, although each hormone has its 
initial interaction with  a  separate receptor.  This 
would explain the ability of multiple hormones to 
activate  liver and  adipose adenylate cyclase and 
would explain why the activation is not additive at 
maximal  hormone  concentrations  (125).  Such  a 
model would also explain how a  hormone  might 
produce multiple biological responses by interac- 
tion of its receptor with several types of effectors. 
In  liver,  for  example,  catecholamine  effects  on 
glycogenolysis appear to be  mediated via cAMP 
while those on gluconeogenesis do not (148). 
The  nature  of the  coupling between  hormone 
binding  to  receptors  and  biological effects  will 
depend on the relative mobility of the two compo- 
nents in the membrane, the probability of a colli- 
sion between the receptor and effector, other in- 
teracting membrane components, and the nature 
of the final linkage between the hormone-receptor 
complex and the effector. The hormone may influ- 
ence the degree of aggregation among receptors, 
the  affinity of the  receptor for  the  effector,  the 
relative mobility of the receptor in the membrane 
plane, or the ability of the receptor to activate the 
effector.  In  some  cases,  it  is  possible  that  the 
hormone  induces  aggregation  or  dissociation of 
receptor subunits. Such models could account for 
the combination of negative cooperativity in bind- 
ing  and  positive  cooperativity  in  biological  re- 
sponse  7 and could provide a mechanism by which 
an oligomeric cluster of noncooperative receptors 
could generate  a  cooperative biological response 
(93). Changes in hormone structure could result in 
changes in the properties of the hormone-receptor 
complex  and  account  for  the  agonist-antagonist 
properties of the molecule. Other factors such as 
ions,  guanyl  nucleotides,  and  changes  in  mem- 
brane iipids might also influence hormone action 
7 De Meyts, P. Personal communication. 
by altering any of the factors involved in the chain 
of events  which  comprise the  functional linkage 
between the receptors and effectors. At present, 
direct demonstration of the migration of receptors 
for peptide hormones or neurotransmitters has not 
been  accomplished.  Several bits of data suggest 
that this type of model may be correct. 
The most direct examples of the possible impor- 
tance of a fluid mosaic membrane with respect to 
the receptors is the demonstration of site-site in- 
teractions among some receptors (see section V, 
3).  While  these  may  be  due  to  conformational 
changes  in  multisubunit protein receptors,  more 
data suggest that the polymerization or depolym- 
erization of clusters of receptors may be impor- 
tant. Electron microscope studies of ferritin-insu- 
lin binding to fat cells and liver membranes have 
demonstrated clustering of receptors (Fig. 5) (71, 
110).  In  addition,  De  Meyts  et  al.  have  found 
that, when  studied as a  function of temperature, 
negative  cooperativity shows  a  sharp  inflection 
point in an Arrhenius plot at about 21~  (27). A 
sharp transition at about this temperature has also 
been associated with formation of clusters in artifi- 
cial lipid bilayers  (86)  or  a  phase  transition  of 
membrane phospholipids (135). In addition, con- 
canavalin A  which inhibits migration of a variety 
of receptors and surface antigens also inhibits the 
site-site interactions among insulin receptors (26). 
Insulin receptors appear to retain their coopera- 
tive properties when  solubilized, suggesting that 
complete membrane  integrity is not required for 
the  site-site  interactions  (51).  Interestingly, the 
soluble  insulin  receptors  appear  to  undergo  a 
change in size when cooperativity is induced (51). 
TSH binding also appears to be related to mem- 
brane  fluidity with  evidence for both  negativity  4 
(146,  151)  and  a  rather  sharp  increase  in  the 
number of TSH receptors at about 30~  (3). Us- 
ing  membrane-bound  fluorescent  probes,  Bach- 
ford  et  al.  found  a  similar temperature  depend- 
ence  of fluorescence  polarization, suggesting  an 
increase  in  thyroidal  membrane  lipid fluidity at 
this temperature (3). Like insulin receptors, TSH 
receptors appear to retain some of their coopera- 
tive properties when removed from the membrane 
by  detergents  (146).  A  relationship  between 
ACTH  binding and  fluidity of membranes  from 
adrenal cortical cells has also been found; in this 
case,  a  temperature  transition occurred  at  23~ 
(3). In a similar line, Craig and Cuatrecasas have 
demonstrated  temperature-dependent  redistribu- 
tion  of cholera  toxin  receptors  (20).  An  abrupt 
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hepatic  adenylate  cyclase  at  temperatures  above 
32~  suggestive of a  cooperative change, has also 
been  observed  (84),  but  at  present  this  has  not 
been correlated with any change in hormone bind- 
ing. 
More  generalized  changes  in  membrane  struc- 
ture in response to hormones have been suggested 
by  spectrofluorometric  studies.  Exposure  of  ap- 
propriate tissues to either human growth hormone 
(131) or TRH  (69) has been found  to result in a 
quenching of intrinsic tryptophan  fluorescence. In 
both cases,  the change results from occupation of 
only  a  small  number  of sites,  and  inactive  ana- 
logues do not produce the effect. Storm and Chase 
(144) also found evidence for a glucagon-induced 
change  in  the  membrane  as  measured  by  en- 
hanced  labeling of a  240,000  mol wt component 
of plasma  membrane  by iodoacetic acid or iodo- 
acetamide in the presence of glucagon. The kinet- 
ics of labeling correlate  well with  the  kinetics  of 
inactivation  of  adenylate  cyclase  by  iodoaceta- 
mide, suggesting that the hormone induced a con- 
formational change in the effector system (adenyl- 
ate cyclase) which resulted  in selective binding of 
some component of this system. 
X.  SUMMARY 
Receptors for peptide hormones and  neurotrans- 
mitters  are  integral  components  of  the  plasma 
membrane of cells which serve to couple the exter- 
nal milieu to the intracellular regulators of metab- 
olism. These macromolecules are usually high mo- 
lecular  weight  glycoproteins,  and  in  many  cases 
appear to have more than one subunit capable of 
binding the hormone.  The interaction of the hor- 
mone  or  neurotransmitter  with  its  receptor  is 
rapid,  reversible, and of high affinity and specific- 
ity. Many receptors exhibit cooperative properties 
in  hormone  binding  or  biological  function.  The 
concentration  of receptors on the membrane  is a 
function  of continued  synthesis  and  degradation, 
and  may be altered by a variety of factors includ- 
ing the hormone itself. The fluid mosaic nature of 
the membrane  may allow hormone  receptors and 
effectors  to  exist  in  free  floating  states.  Further 
investigations of the hormone-receptor interaction 
will  no  doubt  yield  new  insights  into  both  the 
mechanism  of  hormone  action  and  membrane 
structure  and function. 
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